Maryland State Retirement & Pension System Sells 894 Shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT)

Maryland State Retirement & Pension System decreased its position in LeMaitre Vascular, Inc. (NASDAQ:LMAT) by 13.0% during the first quarter, HoldingsChannel reports. The firm owned 5,958 shares of the medical instruments supplier’s stock after selling 894 shares during the quarter. Maryland State Retirement & Pension System’s holdings in LeMaitre Vascular were worth $500,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors also recently modified their holdings of the company. Opal Wealth Advisors LLC bought a new position in shares of LeMaitre Vascular in the first quarter valued at approximately $26,000. NBC Securities Inc. bought a new position in shares of LeMaitre Vascular in the first quarter valued at approximately $36,000. US Bancorp DE raised its position in shares of LeMaitre Vascular by 36.0% in the first quarter. US Bancorp DE now owns 1,390 shares of the medical instruments supplier’s stock valued at $117,000 after purchasing an additional 368 shares during the period. Canada Pension Plan Investment Board raised its position in shares of LeMaitre Vascular by 112.5% in the fourth quarter. Canada Pension Plan Investment Board now owns 1,700 shares of the medical instruments supplier’s stock valued at $157,000 after purchasing an additional 900 shares during the period. Finally, Summit Investment Advisors Inc. raised its position in shares of LeMaitre Vascular by 8.2% in the fourth quarter. Summit Investment Advisors Inc. now owns 2,122 shares of the medical instruments supplier’s stock valued at $196,000 after purchasing an additional 160 shares during the period. Institutional investors own 84.64% of the company’s stock.

Insider Buying and Selling at LeMaitre Vascular

In other news, Director John A. Roush sold 6,561 shares of the business’s stock in a transaction on Monday, August 11th. The shares were sold at an average price of $92.55, for a total value of $607,220.55. Following the sale, the director owned 2,916 shares in the company, valued at approximately $269,875.80. The trade was a 69.23% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CEO George W. Lemaitre sold 100,000 shares of the business’s stock in a transaction on Wednesday, August 6th. The shares were sold at an average price of $93.51, for a total transaction of $9,351,000.00. Following the completion of the sale, the chief executive officer owned 1,727,003 shares in the company, valued at $161,492,050.53. This represents a 5.47% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 202,082 shares of company stock worth $18,249,066 over the last three months. 9.50% of the stock is currently owned by corporate insiders.

LeMaitre Vascular Trading Up 0.7%

Shares of LMAT stock opened at $95.81 on Friday. LeMaitre Vascular, Inc. has a 1 year low of $71.42 and a 1 year high of $109.58. The firm’s fifty day simple moving average is $84.32 and its 200 day simple moving average is $86.56. The firm has a market capitalization of $2.17 billion, a P/E ratio of 46.51, a price-to-earnings-growth ratio of 2.45 and a beta of 0.79. The company has a current ratio of 13.96, a quick ratio of 11.74 and a debt-to-equity ratio of 0.46.

LeMaitre Vascular (NASDAQ:LMAT) last posted its quarterly earnings results on Tuesday, August 5th. The medical instruments supplier reported $0.60 earnings per share for the quarter, topping analysts’ consensus estimates of $0.57 by $0.03. LeMaitre Vascular had a net margin of 20.08% and a return on equity of 13.67%. The firm had revenue of $63.15 million for the quarter, compared to the consensus estimate of $62.48 million. During the same quarter in the previous year, the company earned $0.52 earnings per share. The business’s revenue was up 15.0% compared to the same quarter last year. As a group, sell-side analysts predict that LeMaitre Vascular, Inc. will post 1.94 EPS for the current year.

LeMaitre Vascular Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Thursday, September 4th. Shareholders of record on Thursday, August 21st will be paid a dividend of $0.20 per share. The ex-dividend date is Thursday, August 21st. This represents a $0.80 dividend on an annualized basis and a yield of 0.8%. LeMaitre Vascular’s payout ratio is currently 38.83%.

Analyst Ratings Changes

A number of equities analysts have recently commented on the stock. Cantor Fitzgerald lifted their price target on shares of LeMaitre Vascular from $92.00 to $95.00 and gave the company a “neutral” rating in a research report on Wednesday, August 6th. Barrington Research raised shares of LeMaitre Vascular from a “market perform” rating to an “outperform” rating and set a $95.00 target price on the stock in a research report on Wednesday, August 6th. Four investment analysts have rated the stock with a hold rating and three have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Hold” and an average price target of $98.00.

About LeMaitre Vascular

LeMaitre Vascular, Inc develops, manufactures, and markets medical devices and implants used in the field of vascular surgery worldwide. It offers human cadaver tissue cryopreservation services; angioscope, a fiberoptic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries; thrombectomy catheters for removing thrombi in the venous system; occlusion catheters that temporarily occlude the blood flow; and perfusion catheters to perfuse the blood and other fluids into the vasculature.